Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

LISTEN

Financiado

Cerrado

Liaison in Scientific Training for European auditory Neuroscience

This ITN will train 10 ESRs to meet the urgent need for translation of Auditory Neuroscience into commercial and pharmaceutical products to treat hearing disorders including tinnitus. Tinnitus is the debilitating perception of ima... ver más

30/11/2020

ERASMUS MC

3M€

Presupuesto del proyecto: 3M€

Líder del proyecto

ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDA... No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Fecha límite participación Sin fecha límite de participación.

Ver 8 Participantes

Financiación concedida El organismo H2020 notifico la concesión del proyecto el día 2020-11-30

MSCA-ITN-2016: Innovative Training Networks

I+D

Cerrada hace 9 años

0% 100%

Información adicional privada

No hay información privada compartida para este proyecto. Habla con el coordinador.

8 Participantes

ERASMUS MC

851.25K€ | Lider

KINGS COLLEGE LONDON

273.29K€ | Participante

USAL

247.87K€ | Participante

INSERM

262.88K€ | Participante

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Proyectos interesantes

Tinnitus Platform Commercialization of novel Diagnostic Platform with Synaptic... 71K€ Cerrado

TinniMizer TinniMizer A Patient specific Novel Approach for Tinnitus... 71K€ Cerrado

SAF2016-78898-C2-1-R UNA COMBINACION DE ESTIMULACION TRANSCRANEAL Y OTOPROTECCION... 121K€ Cerrado

EarDiTech Precision Hearing Diagnostics and Augmented-hearing Technolo... 2M€ Cerrado

FJCI-2016-27897 Neurociencia de la Audición 50K€ Cerrado

IBiDT Individualized Binaural Diagnostics and Technology 2M€ Cerrado

Duración del proyecto: 47 meses Fecha Inicio: 2016-12-02
Fecha Fin: 2020-11-30

Líder del proyecto

ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDA... No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Presupuesto del proyecto 3M€

Fecha límite de participación Sin fecha límite de participación.

Descripción del proyecto This ITN will train 10 ESRs to meet the urgent need for translation of Auditory Neuroscience into commercial and pharmaceutical products to treat hearing disorders including tinnitus. Tinnitus is the debilitating perception of imaginary sound that is often associated with hearing loss. This Liaison in Scientific Training for European auditory Neuroscience (LISTEN) is a consortium of top hearing scientists in industry and academia, who specialize in hearing mechanisms and translation to commercial applications, enabling broad career opportunities for our ESRs. The multidisciplinary training environment includes leading labs and companies from 7 EU states, specialized in research, drug and instrumental development. Hearing is vulnerable to noise trauma, medication and aging, and in the future hearing loss will be one of the top ten disease burdens for Europe. Europe must rapidly exploit academic knowledge to invest in treatments for hearing disorders including drug development. Young scientists entering this field must acquire a broad and detailed background in neuroscience, acoustics, biophysics and signal processing, and employ genetic, molecular, pharmacology, anatomy and imaging methods. No single European institute can encompass this, but together, our LISTEN network will enable young scientists and entrepreneurs to unravel hearing mechanisms and design the next-generation of treatments. Work Package 1 (WP1) focuses on neural coding of sounds from the cochlea to neocortex, including auditory processing for localizing sounds and complex cognitive tasks in both normal hearing and following hearing loss. WP2 will identify molecular and genetic mechanisms of the hyperexcitability underlying tinnitus, exploit new techniques for monitoring tinnitus and develop new drug therapies. Integration of the WPs will enable new insights into disease mechanisms and WP3 will provide the ESRs with an essential multidisciplinary background for their research and successful careers.

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores